Omnicell price target lowered to $38 from $40 at Wells Fargo

Wells Fargo lowered the firm’s price target on Omnicell (OMCL) to $38 from $40 and keeps an Equal Weight rating on the shares. The firm is lowering its full-year revenue/EBITDA estimates to low end of guidance range, as Wells is mindful of downstream tariff impacts on equipment costs and exposure to international revenue. The firm believes Q1 was probably spared, with a beat still on the table.